This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abulafia-Lapid, R., Elias, D., et al. (1999) T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J. Autoimmun. 12:121–129.
Adorini, L., Giarratana, N., Penna, G. (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16:127–134.
Adorini, L., Penna, G., Giarratana, N., Uskokovic, M. (2003) Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J. Cell. Biochem. 88:227–233.
Agardh, C. D., Cilio, C. M., Lethagen, A., et al. (2005) Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J. Diabetes Complications 19:238–246.
Aichele, P. (1994) Peptide-induced T-cell tolerance. Proc. Natl. Acad. Sci. U S A 91:444–448.
Akashi, T., Nagafuchi, S., Anzai, K., et al. (1997) Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int. Immunol. 9:1159–1164.
Akbar, A. N., Taams, L. S., Salmon, M., Vukmanovic-Stejic, M. (2003) The peripheral generation of CD4+ CD25+ regulatory T cells. Immunology 109:319–325.
Alleva, D. G., Maki, R. A., Putnam, A. L., et al. (2006) Immunomodulation in type 1 diabetes by NBI-6024, an altered peptide ligand of the insulin B epitope. Scand. J. Immunol. 63:59–69.
Alleva, D. G., Gaur, A., Jin, L., Wegmann, D., et al. (2002) Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9–23) peptide. Diabetes 51:2126–2134.
Alyanakian, M. A., You, S., Damotte, D., et al. (2003) Diversity of regulatory CD4+ T cells controlling distinct organ-specific autoimmune diseases. Proc. Natl. Acad. Sci. U S A 100:15806–15811.
Amrani, A., Verdaguer, J., Serra, P., et al. (2000) Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature 406:739–742.
Anastasi, E., Dotta, F., Tiberti, C., et al. (1999) Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes. Autoimmunity 29:249–256.
Anderson, M. S., Venanzi, E. S., Chen, Z., et al. (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23:227–239.
Anderson, M. S., Venanzi, E. S., Klein, L., et al. (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298:1395–1401.
Andre, I., Gonzalez, A., Wang, B., et al. (1996) Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. U S A 93:2260–2263.
Arif, S., Tree, T. I., Astill, T. P., et al. (2004) Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health. J. Clin. Invest. 113:451–463.
Arreaza, G., Salojin, K., Yang, W., et al. (2003) Deficient activation and resistance to activation-induced apoptosis of CD8+ T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin. Immunol. 107:103–115.
Asano, M., Toda, M., Sakaguchi, N., Sakaguchi, S. (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184:387–396.
Atkinson, M. A., Maclaren, N. K., Luchetta, R. (1990) Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39:933–937.
Bach, J. F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:516–542.
Bach, J. F. (2001) Immunotherapy of insulin-dependent diabetes mellitus. Curr. Opin. Immunol. 13:601–605.
Bach, J. F., Chatenoud, L. (2001) Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:131–161.
Baecher-Allan, C., Viglietta, V., Hafler, D. A. (2004) Human CD4+CD25+ regulatory T cells. Semin. Immunol. 16:89–98.
Baecher-Allan, C., Brown, J. A., Freeman, G. J., Hafler, D. A. (2001) CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 167:1245–1253.
Baekkeskov, S., Aanstoot, H. J., Christgau, S., et al. (1990) Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151–156.
Baker, D., Rosenwasser, O. A., O’Neill, J. K., Turk, J. L. (1995) Genetic analysis of experimental allergic encephalomyelitis in mice. J. Immunol. 155:4046–4051.
Balasa, B., Boehm, B. O., Fortnagel, A., et al. (2001) Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. Clin. Immunol. 99:241–252.
Baumann, E. E., Buckingham, F., Herold, K. C. (1995) Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM. Diabetes 44:871–877.
Baxter, A. G., Horsfall, A. C., Healey, D., et al. (1994) Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology 83:227–231.
Belghith, M., Bluestone, J. A., Barriot, S., et al. (2003) TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9:1202–1208.
Benoist, C., Mathis, D. (1997) Selection for survival? Science 276:2000–2001.
Bercovici, N., Delon, J., Cambouris, C., et al. (1999) Chronic intravenous injections of antigen induce and maintain tolerance in T cell receptor-transgenic mice. Eur. J. Immunol. 29:345–354.
Bercovici, N., Heurtier, A., Vizler, C., et al. (2000) Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage. J. Immunol. 165:202–210.
Bergerot, I., Ploix, C., Petersen, J., et al. (1997) A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes. Proc. Natl. Acad. Sci. U S A 94:4610–4614.
Bertrand, S., De Paepe, M., Vigeant, C., Yale, J. F. (1992) Prevention of adoptive transfer in BB rats by prophylactic insulin treatment. Diabetes 41:1273–1277.
Berzins, S. P., Venanzi, E. S., Benoist, C., Mathis, D. (2003) T-cell compartments of prediabetic NOD mice. Diabetes 52:327–334.
Birk, O. S., Douek, D. C., Elias, D., et al. (1996). A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc. Natl. Acad. Sci. U S A 93:1032–1037.
Blanas, E., Carbone, F. R., Allison, J., et al. (1996) Induction of autoimmune diabetes by oral administration of autoantigen. Science 274:1707–1709.
Bluestone, J. A., Abbas, A. K. (2003) Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3:253–257.
Boden, E., Tang, Q., Bour-Jordan, H., Bluestone, J. A. (2003) The role of CD28 and CTLA4 in the function and homeostasis of CD4+CD25+ regulatory T cells. Novartis Found. Symp. 252:55–63; discussion 63–56, 106–114.
Boitard, C., Yasunami, R., Dardenne, M., Bach, J. F. (1989) T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169:1669–1680.
Charlton, B., Taylor-Edwards, C., Tisch, R., Fathman, C. G. (1994) Prevention of diabetes and insultitis by neonatal intrathymic islet administration in NOD mice. J. Autoimmun. 7:549–560.
Chatenoud, L. (1982) Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur. J. Immunol. 12:979–982.
Chatenoud, L. (2001) Restoration of self-tolerance is a feasible approach to control ongoing beta-cell specific autoreactivity: its relevance for treatment in established diabetes and islet transplantation. Diabetologia 44:521–536.
Chatenoud, L. (2002) The use of monoclonal antibodies to restore self-tolerance in established autoimmunity. Endocrinol. Metab. Clin. North Am. 31:457–475, ix.
Chatenoud, L., Primo, J., Bach, J. F. (1997) CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158:2947–2954.
Chatenoud, L., Salomon, B., Bluestone, J. A. (2001) Suppressor T cells—they’re back and critical for regulation of autoimmunity! Immunol. Rev. 182:149–163.
Chatenoud, L., Thervet, E., Primo, J., Bach, J. F. (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U S A 91:123–127.
Chentoufi, A. A., Polychronakos, C. (2002) Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51:1383–1390.
Chilton, P. M., Rezzoug, F., Fugier-Vivier, I., et al. (2004) Flt3-ligand treatment prevents diabetes in NOD mice. Diabetes 53:1995–2002.
Choisy-Rossi, C. M., Holl, T. M., Pierce, M. A., et al. (2004) Enhanced pathogenicity of diabetogenic T cells escaping a non-MHC gene-controlled near death experience. J. Immunol. 173:3791–3800.
Dahlen, E., Hedlund, G., Dawe, K. (2000) Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation. J. Immunol. 164:2444–2456.
Daniel, D., Wegmann, D. R. (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9–23). Proc. Natl. Acad. Sci. U S A 93:956–960.
Daniel, D., Gill, R. G., Schloot, N., Wegmann, D. (1995) Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25:1056–1062.
Danke, N. A., Yang, J., Greenbaum, C., Kwok, W. W. (2005) Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25:303–311.
Danke, N. A., Koelle, D. M., Yee, C., et al. (2004) Autoreactive T cells in healthy individuals. J. Immunol. 172:5967–5972.
Dardenne, M., Lepault, F., Bendelac, A., Bach, J. F. (1989) Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning. Eur. J. Immunol. 19:889–895.
Delovitch, T. L., Singh, B. (1997) The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727–738.
Dieckmann, D., Plottner, H., Berchtold, S., et al. (2001) Ex vivo isolation and characterization of CD4(+) CD25(+) T cells with regulatory properties from human blood. J. Exp. Med. 193:1303–1310.
Dotta, F., Dionisi, S., Viglietta, V., et al. (1999) T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. Eur. J. Endocrinol. 141:272–278.
DPT1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus. N. Engl. J. Med. 346:1685–1691.
Dubois-Lafforgue, D., Mogenet, L., Thebault, K., et al. (2002) Proinsulin 2 knockout NOD mice: a model for genetic variation of insulin gene expression in type 1 diabetes. Diabetes 51(Suppl 3):S489–S493.
Eisenbarth, G. S., Srikanta, S., Jackson, R., et al. (1985) Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. Diabetes Res. 2:271–276.
Elias, D., Cohen, I. R. (1995) Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277. Diabetes 44:1132–1138.
Elias, D., Cohen, I. R. (1996) The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin. Diabetes 45:1168–1172.
Elias, D., Reshef, T., Birk, O. S., et al. (1991) Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc. Natl. Acad. Sci. U S A 88:3088–3091.
Elias, D., Prigozin, H., Polak, N., et al. (1994) Autoimmune diabetes induced by the beta-cell toxin STZ:immunity to the 60-kDa heat shock protein and to insulin. Diabetes 43:992–998.
Elias, D., Meilin, A., Ablamunits, V., et al. (1997) Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes 46:758–764.
Elliott, J. (1994) Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 43:1494–1499.
Elliott, R. B., Crossley, J. R., Berryman, C. C., James, A. G. (1981) Partial preservation of pancreatic beta-cell function in children with diabetes. Lancet 2:1–4.
Feili-Hariri, M., Morel, P. A. (2001) Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin. Immunol. 98:133–142.
Feili-Hariri, M., Falkner, D. H., Morel, P. A. (2002) Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice. Eur. J. Immunol. 32:2021–2030.
Feutren, G., Papoz, L., Assan, R., Vialettes, B., et al. (1986) Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial. Lancet 19:119–124.
Filippi, C., Bresson, D., von Herrath, M. (2005) Antigen-specific induction of regulatory T cells for type 1 diabetes therapy. Int. Rev. Immunol. 24:341–360.
Fontenot, J. D., Rudensky, A. Y. (2005) A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6:331–337.
Gavin, M., Rudensky, A. (2003) Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 15:690–696.
Gerling, I. C., Serreze, D. V., Christianson, S. W., Leiter, E. H. (1992) Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice. Diabetes 41:1672–1676.
Ghosh, S., Palmer, S. M., Rodrigues, N. R., et al. (1993) Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4:404–409.
Gianani, R., Eisenbarth, G. S. (2005) The stages of type 1A diabetes: 2005. Immunol. Rev. 204:232–249.
Girao, C., Hu, Q., Sun, J., Ashton-Rickardt, P. G. (1997) Limits to the differential avidity model of T cell selection in the thymus. J. Immunol. 159:4205–4211.
Godfrey, W. R., Ge, Y. G., Spoden, D. J., et al. (2004) In vitro-expanded human CD4(+) CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104:453–461.
Gotfredsen, C. F. (1985) Reduction of diabetes incidence of BB Wistar rats by early prophylactic insulin treatment of diabetes-prone animals. Diabetologia 28:933–935.
Goudy, K., Song, S., Wasserfall, C., et al. (2001) Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc. Natl. Acad. Sci. U S A 98:13913–13918.
Goudy, K. S., Tisch, R. (2005) Immunotherapy for the prevention and treatment of type 1 diabetes. Int. Rev. Immunol. 24:307–326.
Goudy, K. S., Burkhardt, B. R., Wasserfall, C., et al. (2003) Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J. Immunol. 171:2270–2278.
Gregg, R. K., Bell, J. J., Lee, H. H., et al. (2005) IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance. J. Immunol. 174:662–670.
Gregori, S., Giarratana, N., Smiroldo, S., Adorini, L. (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171:4040–4047.
Gregori, S., Giarratana, N., Smiroldo, S., et al. (2002) A 1alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367–1374.
Grohmann, U., Fallarino, F., Bianchi, R., et al. (2003) A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J. Exp. Med. 198:153–160.
Han, B., Serra, P., Amrani, A., et al. (2005) Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide. Nat. Med. 11:645–652.
Hanahan, D. (1998) Peripheral-antigen-expressing cells in thymic medulla: factors in self-tolerance and autoimmunity. Curr. Opin. Immunol. 10:656–662.
Hancock, W. W. (1995) Suppression of insulitis in non-obese diabetic (NOD) mice by oral insulin administration is associated with selective expression of interleukin-4 and -10, transforming growth factor-beta, and prostaglandin-E. Am. J. Pathol. 147:1193–1199.
Hanninen, A. (2000) Gamma delta T cells as mediators of mucosal tolerance: the autoimmune diabetes model. Immunol. Rev. 173:109–119.
Harrison, L. C., Dempsey-Collier, M., Kramer, D. R., Takahashi, K. (1996) Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184:2167–2174.
Harrison, L. C., Honeyman, M. C., Steele, C. E., et al. (2004) Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes. Diabetes Care 27:2348–2355.
Haskins, K., Wegmann, D. (1996) Diabetogenic T-cell clones. Diabetes 45:1299–1305.
Hassainya, Y., Garcia-Pons, F., Kratzer, R., et al. (2005) Identification of naturally processed HLA-A2-restricted proinsulin epitopes by reverse immunology. Diabetes 54:2053–2059.
Hayward, A. R. (1989) Neonatal injection of CD3 antibody into nonobese diabetic reduces the incidence of insulitis and diabetes. J. Immunol. 143:1555–1559.
Heath, V. L., Hutchings, P., Fowell, D. J., et al. (1999) Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes. Diabetes 48:2157–2165.
Heath, W. R., Allison, J., Hoffmann, M. W., et al. (1992) Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359:547–549.
Herbelin, A., Gombert, J. M., Lepault, F., et al. (1998) Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate “active tolerance” in the nonobese diabetic mouse. J. Immunol. 161:2620–2628.
Herman, A. E., Freeman, G. J., Mathis, D., Benoist, C. (2004) CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199:1479–1489.
Herold, K. C., Montag, A. G., Buckingham, F. (1992) Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176:1107–1114.
Herold, K. C., Burton, J. B., Francois, F., et al. (2003) Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala). J. Clin. Invest. 111:409–418.
Herold, K. C., Hagopian, W., Auger, J. A., et al. (2002) Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346:1692–1698.
Hoffmann, P., Eder, R., Kunz-Schughart, L. A., et al. (2004) Large-scale in vitro expansion of polyclonal human CD4(+) CD25high regulatory T cells. Blood 104:895–903.
Homann, D., Holz, A., Bot, A., et al. (1999) Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11:463–472.
Honeyman, M. C., Cram, D. S., Harrison, L. C. (1993). Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J. Exp. Med. 177:535–540.
Horwitz, D. A., Zheng, S. G., Gray, J. D., et al. (2004) Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin. Immunol. 16:135–143.
Hutchings, P. R., Cooke, A. (1990) The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. J. Autoimmun. 3:175–185.
Jenkins, M. K., Chen, C. A., Jung, G., et al. (1990) Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:16–22.
Jonuleit, H., Schmitt, E., Schuler, G., et al. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213–1222.
Jun, H. S., Chung, Y. H., Han, J., et al. (2002) Prevention of autoimmune diabetes by immunogene therapy using recombinant vaccinia virus expressing glutamic acid decarboxylase. Diabetologia 45:668–676.
Kanagawa, O., Militech, A., Vaupel, B. A. (2002) Regulation of diabetes development by regulatory T cells in pancreatic islet antigen-specific TCR transgenic nonobese diabetic mice. J. Immunol. 168:6159–6164.
Karounos, D. G. (1997) Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice. J. Clin. Invest. 100:1344–1348.
Kaufman, D. L. (1993) Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69–72.
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., et al. (2005) Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N. Engl. J. Med. 352:2598–2608.
Kishimoto, H., Sprent, J. (1999) Several different cell surface molecules control negative selection of medullary thymocytes. J. Exp. Med. 190:65–73.
Kishimoto, H., Sprent, J. (2001) A defect in central tolerance in NOD mice. Nat. Immunol. 2:1025–1031.
Klein, L., Klein, T., Ruther, U., Kyewski, B. (1998) CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J. Exp. Med. 188:5–16.
Koevary, S. B., Blomberg, M. (1992) Prevention of diabetes in BB/Wor rats by intrathymic islet injection. J. Clin. Invest. 89:512–516.
Kreuwel, H. T., Biggs, J. A., Pilip, I. M., et al. (2001) Defective CD8+ T cell peripheral tolerance in nonobese diabetic mice. J. Immunol. 167:1112–1117.
Kukreja, A., Cost, G., Marker, J., et al. (2002) Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109:131–140.
Kurts, C., Sutherland, R. M., Davey, G., et al. (1999) CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. U S A 96:12703–12707.
Lang, J., Bellgrau, D. (2004) Animal models of type 1 diabetes: genetics and immunological function. Adv. Exp. Med. Biol. 552:91–116.
Lanoue, A., Bona, C., von Boehmer, H., Sarukhan, A. (1997) Conditions that induce tolerance in mature CD4+ T cells. J. Exp. Med. 185:405–414.
Lehmann, J., Huehn, J., de la Rosa, M., et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. U S A 99:13031–13036.
Lepault, F., Gagnerault, M. C. (2000) Characterization of peripheral regulatory CD4+ T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164:240–247.
Lepault, F., Gagnerault, M. C., Faveeuw, C., et al. (1995) Lack of L-selection expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur. J. Immunol. 25:1502–1507.
Lesage, S., Hartley, S. B., Akkaraju, S., et al. (2002) Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes. J. Exp. Med. 196:1175–1188.
Li, A. F., Escher, A. (2003) Intradermal or oral delivery of GAD-encoding genetic vaccines suppresses type 1 diabetes. DNA Cell Biol. 22:227–232.
Lieberman, S. M., Takaki, T., Han, B., et al. (2004) Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase. J. Immunol. 173:6727–6734.
Lieberman, S. M., Evans, A. M., Han, B., et al. (2003) Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. U S A 100:8384–8388.
Lindley, S., Dayan, C. M., Bishop, A., et al. (2005) Defective suppressor function in CD4(+) CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54:92–99.
Liston, A., Goodnow, C. C. (2005) Genetic lesions in thymic T cell clonal deletion and thresholds for autoimmunity. Novartis Found. Symp. 267:180–192; discussion 192–189.
Liston, A., Lesage, S., Wilson, J., et al. (2003) Aire regulates negative selection of organ-specific T cells. Nat. Immunol. 4:350–354.
Liston, A., Gray, D. H., Lesage, S., et al. (2004a) Gene dosage-limiting role of Aire in thymic expression, clonal deletion, and organ-specific autoimmunity. J. Exp. Med. 200:1015–1026.
Liston, A., Lesage, S., Gray, D. H., et al. (2004b) Generalized resistance to thymic deletion in the NOD mouse; a polygenic trait characterized by defective induction of Bim. Immunity 21:817–830.
Liu, E., Moriyama, H., Abiru, N., et al. (2002) Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9–23 and B:13–23. J. Clin. Invest. 110:1021–1027.
Lohmann, T., Leslie, R. D., Londei, M. (1996) T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9:385–389.
Lohr, J., Knoechel, B., Nagabhushanam, V., Abbas, A. K. (2005) T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol. Rev. 204:116–127.
Macian, F., Garcia-Cozar, F., Im, S. H., et al. (2002) Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109:719–731.
Maki, T., Ichikawa, T., Blanco, R., Porter, J. (1992) Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc. Natl. Acad. Sci. U S A 89:3434–3438.
Mallone, R., Kochik, S. A., Laughlin, E. M., et al. (2004) Differential recognition and activation thresholds in human autoreactive GAD-specific T-cells. Diabetes 53:971–977.
Maron, R., Melican, N. S., Weiner, H. L. (1999) Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes. J. Autoimmun. 12:251–258.
Martin, C. C., Bischof, L. J., Bergman, B., et al. (2001) Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J. Biol. Chem. 276:25197–25207.
Masteller, E. L., Warner, M. R., Tang, Q., et al. (2005) Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice. J. Immunol. 175:3053–3059.
Masteller, E. L., Warner, M. R., Ferlin, W., et al. (2003) Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes. J. Immunol. 171:5587–5595.
Mathis, D., Benoist, C. (2004) Back to central tolerance. Immunity 20:509–516.
McHugh, R. S., Whitters, M. J., Piccirillo, C. A., et al. (2002) CD4(+) CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311–323.
Menard, V., Jacobs, H., Jun, H. S., et al. (1999) Anti-GAD monoclonal antibody delays the onset of diabetes mellitus in NOD mice. Pharm. Res. 16:1059–1066.
Metzler, B., Anderton, S. M., Manickasingham, S. P., Wraith, D. C. (2000) Kinetics of peptide uptake and tissue distribution following a single intranasal dose of peptide. Immunol. Invest. 29:61–70.
Morgan, D. J., Liblau, R., Scott, B., et al. (1996) CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. J. Immunol. 157:978–983.
Moritani, M., Yoshimoto, K., Tashiro, F., et al. (1994) Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927–1936.
Moriyama, H., Abiru, N., Paronen, J., et al. (2003) Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc. Natl. Acad. Sci. U S A 100:10376–10381.
Mosmann, T. R., Coffman, R. L. (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145–173.
Muir, A. (1995) Insulin immunization of nonobese diabetic mice induces a protective insulitis characterized by diminished intraislet interferon-gamma transcription. J. Clin. Invest. 95:628–634.
Mukherjee, R., Chaturvedi, P., Qin, H. Y., Singh, B. (2003) CD4+CD25+ regulatory T cells generated in response to insulin B:9–23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells. J. Autoimmun. 21:221–237.
Myers, M. A., Laks, M. R., Feeney, S. J., et al. (1998) Antibodies to ICA512/IA-2 in rodent models of IDDM. J. Autoimmun. 11:265–272.
Nakamura, K., Kitani, A., Strober, W. (2001) Cell contact-dependent immunosuppression by CD4(+) CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194:629–644.
Nakayama, M., Abiru, N., Moriyama, H., et al. (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223.
Nomura, Y., Stein, E., Mullen, Y. (1993) Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobese diabetic (NOD) mice. Transplantation 56:638–642.
Noorchashm, H., Noorchashm, N., Kern, J., et al. (1997) B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes 46:941–946.
Ohashi, P. S. (2003) Negative selection and autoimmunity. Curr. Opin. Immunol. 15:668–676.
Ohashi, P. S., Oehen, S., Buerki, K., et al. (1991) Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305–317.
Oldenborg, P. A., Gresham, H. D., Chen, Y., et al. (2002) Lethal autoimmune hemolytic anemia in CD47-deficient nonobese diabetic (NOD) mice. Blood 99:3500–3504.
Oling, V., Marttila, J., Ilonen, J., et al. (2005) GAD65- and proinsulin-specific CD4+ T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects. J. Autoimmun. 25:235–243.
Oukka, M., Cohen-Tannoudji, M., Tanaka, Y., et al. (1996a) Medullary thymic epithelial cells induce tolerance to intracellular proteins. J. Immunol. 156:968–975.
Oukka, M., Colucci-Guyon, E., Tran, P. L., et al. (1996b) CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 4:545–553.
Panina-Bordignon, P., Lang, R., van Endert, P. M., et al. (1995) Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181:1923–1927.
Pedersen, A. E., Gad, M., Walter, M. R., Claesson, M. H. (2004) Induction of regulatory dendritic cells by dexamethasone and 1 alpha, 25-dihydroxyvitamin D(3). Immunol. Lett. 91:63–69.
Peng, Y., Laouar, Y., Li, M. O., et al. (2004) TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. U S A 101:4572–4577.
Penna, G., Roncari, A., Amuchastegui, S., et al. (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+ Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3. Blood 106:3490–3497.
Pennline, K. J., Roque-Gaffney, E., Monahan, M. (1994) Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse. Clin. Immunol. Immunopathol. 71:169–175.
Petersen, J. S., Bregenholt, S., Apostolopolous, V., et al. (2003) Coupling of oral human or porcine insulin to the B subunit of cholera toxin (CTB) overcomes critical antigenic differences for prevention of type I diabetes. Clin. Exp. Immunol. 134:38–45.
Ploix, C., Bergerot, I., Fabien, N., et al. (1998) Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes 47:39–44.
Ploix, C., Bergerot, I., Durand, A., et al. (1999) Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells. Diabetes 48:2150–2156.
Pociot, F., McDermott, M. F. (2002) Genetics of type 1 diabetes mellitus. Genes Immun. 3:235–249.
Polanski, M., Melican, N. S., Zhang, J., Weiner, H. L. (1997) Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines. J. Autoimmun. 10:339–346.
Pop, S. M., Wong, C. P., Culton, D. A., et al. (2005) Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J. Exp. Med. 201:1333–1346.
Posselt, A. M., Barker, C. F., Friedman, A. L., Naji, A. (1992) Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256:1321–1324.
Pozzilli, P. (2002) The DPT-1 trial: a negative result with lessons for future type 1 diabetes prevention. Diabetes Metab. Res. Rev. 18:257–259.
Pozzilli, P., Pitocco, D., Visalli, N., et al. (2000) No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group. Diabetologia 43:1000–1004.
Prasad, S. J., Goodnow, C. C. (2002) Intrinsic in vitro abnormalities in dendritic cell generation caused by non-MHC non-obese diabetic genes. Immunol. Cell Biol. 80:198–206.
Pugliese, A., Zeller, M., Fernandez, A., Jr., et al. (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat. Genet. 15:293–297.
Putnam, A. L., Vendrame, F., Dotta, F., Gottlieb, P. A. (2005) CD4+CD25high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24:55–62.
Radu, D. L., Brumeanu, T. D., McEvoy, R. C., et al. (1999) Escape from self-tolerance leads to neonatal insulin-dependent diabetes mellitus. Autoimmunity 30:199–207.
Ramiya, V. (1996) Antigen based therapies to prevent diabetes in NOD mice. J. Autoimmun. 9:349–356.
Ramsdell, F. (2003) Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity 19:165–168.
Raz, I., Elias, D., Avron, A., et al. (2001) Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. Lancet 358:1749–1753.
Reijonen, H., Kwok, W. W., Nepom, G. T. (2003) Detection of CD4+ autoreactive T cells in T1D using HLA class II tetramers. Ann. N. Y. Acad. Sci. 1005:82–87.
Reijonen, H., Novak, E. J., Kochik, S., et al. (2002) Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects. Diabetes 51:1375–1382.
Reijonen, H., Mallone, R., Heninger, A. K., et al. (2004) GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 53:1987–1994.
Rivero, V. E., Cailleau, C., Depiante-Depaoli, M., et al. (1998) Non-obese diabetic (NOD) mice are genetically susceptible to experimental autoimmune prostatitis (EAP). J. Autoimmun. 11:603–610.
Roncarolo, M. G., Bacchetta, R., Bordignon, C., et al. (2001) Type 1 T regulatory cells. Immunol. Rev. 182:68–79.
Rosmalen, J. G., van Ewijk, W., Leenen, P. J. (2002) T-cell education in autoimmune diabetes: teachers and students. Trends Immunol. 23:40–46.
Sai, P., Rivereau, A. S., Granier, C., et al. (1996) Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524–543 reduces cyclophosphamide-accelerated diabetes. Clin. Exp. Immunol. 105:330–337.
Sakaguchi, S. (2000) Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455–458.
Sakaguchi, S. (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22:531–562.
Sakaguchi, S., Sakaguchi, N., Asano, M., et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151–1164.
Salomon, B., Lenschow, D. J., Rhee, L., et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431–440.
Saoudi, A., Seddon, B., Fowell, D., Mason, D. (1996) The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients. J. Exp. Med. 184:2393–2398.
Schwartz, R. H. (1990) A cell culture model for T lymphocyte clonal anergy. Science 248:1349–1356.
Schwartz, R. H. (2003) T cell anergy. Annu. Rev. Immunol. 21:305–334.
Scott, B., Liblau, R., Degermann, S., et al. (1994) A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1:73–83.
Seddon, B., Mason, D. (1999) Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+) CD45RC-cells and CD4(+) CD8(-) thymocytes. J. Exp. Med. 189:279–288.
Semana, G., Gausling, R., Jackson, R. A., Hafler, D. A. (1999) T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J. Autoimmun. 12:259–267.
Serreze, D. V., Chen, Y. G. (2005) Of mice and men: use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans. Trends Immunol. 26:603–607.
Serreze, D. V., Gaedeke, J. W., Leiter, E. H. (1993) Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. U S A 90:9625–9629.
Serreze, D. V., Chapman, H. D., Varnum, D. S., et al. (1996) B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new “speed congenic” stock of NOD.Ig mu null mice. J. Exp. Med. 184:2049–2053.
Shoda, L. K., Young, D. L., Ramanujan, S., et al. (2005) A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23:115–126.
Silverstein, J., Maclaren, N., Riley, W., et al. (1988) Immunosuppression with azathioprine and prednisone in recent-onset insulin-dependent diabetes mellitus. N. Engl. J. Med. 319:599–604.
Skyler, J. S., Krischer, J. P., Wolfsdorf, J., et al. (2005) Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial—Type 1. Diabetes Care 28:1068–1076.
Solomon, M., Sarvetnick, N. (2004) The pathogenesis of diabetes in the NOD mouse. Adv. Immunol. 84:239–264.
Steinman, R. M., Hawiger, D., Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21:685–711.
Stephens, L. A., Mason, D. (2000) CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations. J. Immunol. 165:3105–3110.
Stephens, L. A., Mottet, C., Mason, D., Powrie, F. (2001) Human CD4(+) CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31:1247–1254.
Strid, J., Lopes, L., Marcinkiewicz, J., et al. (2001) A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin. Exp. Immunol. 123:375–381.
Suri-Payer, E., Kehn, P. J., Cheever, A. W., Shevach, E. M. (1996) Pathogenesis of post-thymectomy autoimmune gastritis: identification of anti-H/K adenosine triphosphatase-reactive T cells. J. Immunol. 157:1799–1805.
Suri-Payer, E., Amar, A. Z., Thornton, A. M., Shevach, E. M. (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160:1212–1218.
Takaki, T., Marron, M. P., Mathews, C. E., et al. (2006) HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J. Immunol. 176:3257–3265.
Tang, Q., Henriksen, K. J., Bi, M., et al. (2004). In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199:1455–1465.
Tarbell, K. V., Yamazaki, S., Olson, K., et al. (2004). CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199:1467–1477.
Tian, J., Lehmann, P. V., Kaufman, D. L. (1997) Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039–2043.
Tian, J., Olcott, A. P., Kaufman, D. L. (2002) Antigen-based immunotherapy drives the precocious development of autoimmunity. J. Immunol. 169:6564–6569.
Tian, J., Atkinson, M. A., Clare-Salzler, M., et al. (1996a) Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561–1567.
Tian, J., Clare-Salzler, M., Herschenfeld, A., et al. (1996b) Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nat. Med. 2:1348–1353.
Tisch, R., Wang, B., Serreze, D. V. (1999) Induction of glutamic acid decarboxylase 65-specific Th2 cells and suppression of autoimmune diabetes at late stages of disease is epitope dependent. J. Immunol. 163:1178–1187.
Tisch, R., Liblau, R. S., Yang, X. D., et al. (1998) Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice. Diabetes 47:894–899.
Tisch, R., Yang, X. D., Singer, S. M., et al. (1993) Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72–75.
Tisch, R., Wang, B., Weaver, D. J., et al. (2001) Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J. Immunol. 166:2122–2132.
Toes, R., Offringa, R. (1996) Peptide vaccination can lead to. Proc. Natl. Acad. Sci. USA 93:7855–7860.
Tone, M., Tone, Y., Adams, E., et al. (2003) Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100:15059–15064.
Trembleau, S., Penna, G., Gregori, S., et al. (2000) Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J. Immunol. 165:6748–6755.
Ucker, D. S., Meyers, J., Obermiller, P. S. (1992) Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol. 149:1583–1592.
Urbanek-Ruiz, I., Ruiz, P. J., Paragas, V., et al. (2001) Immunization with DNA encoding an immunodominant peptide of insulin prevents diabetes in NOD mice. Clin. Immunol. 100:164–171.
Vafiadis, P., Bennett, S. T., Todd, J. A., et al. (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15:289–292.
Venanzi, E. S., Benoist, C., Mathis, D. (2004) Good riddance: thymocyte clonal deletion prevents autoimmunity. Curr. Opin. Immunol. 16:197–202.
Vogel, A., Strassburg, C. P., Obermayer-Straub, P., et al. (2002) The genetic background of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy and its autoimmune disease components. J. Mol. Med. 80:201–211.
Von Herrath, M. G., Harrison, L. C. (2003) Antigen-induced regulatory T cells in autoimmunity. Nat. Rev. Immunol. 3:223–232.
Von Herrath, M. G., Dockter, J., Oldstone, M. B. (1994) How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1:231–242.
Von Herrath, M. G., Guerder, S., Lewicki, H., et al. (1995) Coexpression of B7–1 and viral (“self”) transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727–738.
Walker, L. S., Abbas, A. K. (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol. 2:11–19.
Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., et al. (2003) Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J. Clin. Invest. 112:1437–1443.
Wang, B., Gonzalez, A., Hoglund, P., et al. (1998) Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47:1207–1211.
Weaver, D. J., Jr., Liu, B., Tisch, R. (2001) Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J. Immunol. 167:586–592.
Wegmann, D. R., Norbury-Glaser, M., Daniel, D. (1994a) Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24:1853–1857.
Wegmann, D. R., Gill, R. G., Norbury-Glaser, M., et al. (1994b) Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7:833–843.
Weiner, H. L. (2001a) Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect. 3:947–954.
Weiner, H. L. (2001b) The mucosal milieu creates tolerogenic dendritic cells and T(R) 1 and T(H) 3 regulatory cells. Nat. Immunol. 2:671–672.
Wicker, L. S., Todd, J. A., Peterson, L. B. (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:179–200.
Wilson, S. S., White, T. C., DeLuca, D. (2001) Therapeutic alteration of insulin-dependent diabetes mellitus progression by T cell tolerance to glutamic acid decarboxylase 65 peptides in vitro and in vivo. J. Immunol. 167:569–577.
Wogensen, L., Lee, M. S., Sarvetnick, N. (1994) Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice. J. Exp. Med. 179:1379–1384.
Wong, F. S., Visintin, I., Wen, L., et al. (1996) CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183:67–76.
Wong, S., Guerder, S., Visintin, I., et al. (1995) Expression of the co-stimulator molecule B7–1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes 44:326–329.
Wu, Q., Salomon, B., Chen, M., et al. (2001) Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J. Exp. Med. 193:1327–1332.
Yamamoto, A. M., Chernajovsky, Y., Lepault, F., et al. (2001) The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy. J. Immunol. 166:4973–4980.
Yang, J., Danke, N. A., Berger, D., et al. (2006) Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects. J. Immunol. 176:2781–2789.
Yoon, J. W., Yoon, C. S., Lim, H. W., et al. (1999) Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284:1183–1187.
You, S., Slehoffer, G., Barriot, S., et al. (2004) Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 101(Suppl 2):14580–14585.
You, S., Thieblemont, N., Alyanakian, M. A., et al. (2006) TGF-beta and T-cell mediated immunoregulation in the control of autoimmune diabetes. Annu Rev Immunol, 212:185–202.
You, S., Chen, C., Lee, W. H., et al. (2003) Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides. J. Immunol. 170:4011–4020.
You, S., Belghith, M., Cobbold, S., et al. (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes 54:1415–1422.
Yu, J., Yu, L., Bugawan, T. L., et al. (2000) Transient antiislet autoantibodies: infrequent occurrence and lack of association with “genetic” risk factors. J. Clin. Endocrinol. Metab. 85:2421–2428.
Zaccone, P., Fehervari, Z., Blanchard, L., et al. (2002) Autoimmune thyroid disease induced by thyroglobulin and lipopolysaccharide is inhibited by soluble TNF receptor type I. Eur. J. Immunol. 32:1021–1028.
Zanin-Zhorov, A., Bruck, R., Tal, G., et al. (2005) Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines. J. Immunol. 174:3227–3236.
Zechel, M. (1998a) Characterization of novel T-cell epitopes on 65 kDa and 67 kDa glutamic acid decarboxylase relevant in autoimmune responses in NOD mice. J. Autoimmun. 11:83–95.
Zechel, M. (1998b) Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol. Rev. 164:111–118.
Zelenika, D., Adams, E., Humm, S., et al. (2002) Regulatory T cells overexpress a subset of Th2 gene transcripts. J. Immunol. 168:1069–1079.
Zhang, Z. J., Davidson, L., Eisenbarth, G., Weiner, H. L. (1991) Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin. Proc. Natl. Acad. Sci. USA 88:10252–10256.
Zipris, D., Lazarus, A. H., Crow, A. R., et al. (1991) Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 146:3763–3771.
Zucchelli, S., Holler, P., Yamagata, T., et al. (2005) Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 22:385–396.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Candon, S., Chatenoud, L., Bach, JF. (2007). Molecular Basis for Induction of Tolerance in Type I Diabetes. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-36003-4_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36002-7
Online ISBN: 978-0-387-36003-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)